Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE：SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries and/or associate companies) today announced that its wholly-owned Japanese
The next step in precision medicine lies in decentralizing comprehensive biomarker testing Envisioned to drive a new standard of cancer care, HealthCare Global Enterprises Limited
Biocon Limited (BSE: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, announced today that Anupam Jindal has been appointed as the company’s new Chief
Focuses on AI in Histopathology with emphasis on Breast Cancer Continuing with its transformative efforts in the field of Artificial Intelligence in Pathology, SRL Diagnostics,
In a case that provides hope for the treatment of patients suffering from covid19, medical specialists at Aster CMI Hospital successfully revived and gave
The team has shown results in treating Rabbits & is exploring funding opportunities for applications in Humans as Magnesium is the 4th abundant metal in
The eminent panellists present were Dr. Anil Khurana, Director General, Central Council for Research in Homoeopathy, Dr. R. K. Manchanda, Director AYUSH, Govt. of
· India’s first CRISPR Covid-19 test, developed by the Tata Group and CSIR-IGIB, has been approved for use in India. The Tata CRISPR test, powered by CSIR-IGIB
Niramai Health Analytix, India’s foremost and innovative AI-based breast cancer screening company has tied-up with Apollo Clinic, India’s leading multi-specialty clinics by Apollo Health